These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24462399)

  • 21. Torsade de pointes and low-dose oral haloperidol.
    Jackson T; Ditmanson L; Phibbs B
    Arch Intern Med; 1997 Sep; 157(17):2013-5. PubMed ID: 9308514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Torsade de pointes associated with encephalitis.
    Alehan D; Ceviz N; Celiker A
    Turk J Pediatr; 1999; 41(3):395-8. PubMed ID: 10770105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Torsade de pointes induced by quinidine: a case treated successfully with verapamil].
    Ometto R; Arfiero S; Vincenzi M
    G Ital Cardiol; 1990 May; 20(5):431-4. PubMed ID: 2210166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Torsades de pointes therapy with phenytoin.
    Vukmir RB; Stein KL
    Ann Emerg Med; 1991 Feb; 20(2):198-200. PubMed ID: 1996806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isoproterenol as an adjunct for treatment of idiopathic ventricular fibrillation storm in a pregnant woman.
    Mittadodla PS; Salen PN; Traub DM
    Am J Emerg Med; 2012 Jan; 30(1):251.e3-5. PubMed ID: 21075581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Torsade de pointes associated with Astemizole overdose treated with magnesium sulfate.
    Hasan RA; Zureikat GY; Nolan BM
    Pediatr Emerg Care; 1993 Feb; 9(1):23-5. PubMed ID: 8488140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mexiletine antagonizes effects of sotalol on QT interval duration and its proarrhythmic effects in a canine model of torsade de pointes.
    Chézalviel-Guilbert F; Davy JM; Poirier JM; Weissenburger J
    J Am Coll Cardiol; 1995 Sep; 26(3):787-92. PubMed ID: 7642874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing predictors of drug-induced torsade de pointes.
    Belardinelli L; Antzelevitch C; Vos MA
    Trends Pharmacol Sci; 2003 Dec; 24(12):619-25. PubMed ID: 14654302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ['Cardiac ballet' with and without amiodarone].
    Balestra B; Hess T
    Schweiz Med Wochenschr; 1993 Jan; 123(1-2):20-5. PubMed ID: 8421775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel therapeutics for treatment of long-QT syndrome and torsade de pointes.
    Khan IA; Gowda RM
    Int J Cardiol; 2004 May; 95(1):1-6. PubMed ID: 15159030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accuracy of uncorrected versus corrected QT interval for prediction of torsade de pointes associated with intravenous haloperidol.
    Tisdale JE; Kovacs R; Mi D; McCabe GP; Cariera BL; Sharma N; Rosman H
    Pharmacotherapy; 2007 Feb; 27(2):175-82. PubMed ID: 17253907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monotherapy versus combination therapy with class III antiarrhythmic agents to attenuate transmural dispersion of repolarization: a potential risk factor for torsade de pointes.
    Shah SA; Kluger J; White CM
    Pharmacotherapy; 2007 Sep; 27(9):1297-305. PubMed ID: 17723083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. QT interval prolongation, torsade de pointes and renal disease.
    Patanè S; Marte F; Di Bella G; Currò A; Coglitore S
    Int J Cardiol; 2008 Nov; 130(2):e71-3. PubMed ID: 18255176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sulpiride-associated torsade de pointes in a woman with bipolar disorder.
    Teng PR; Shen TY; Lai TJ
    Psychiatry Clin Neurosci; 2012 Apr; 66(3):246. PubMed ID: 22443253
    [No Abstract]   [Full Text] [Related]  

  • 35. Torsade de pointes: the clinical considerations.
    Gowda RM; Khan IA; Wilbur SL; Vasavada BC; Sacchi TJ
    Int J Cardiol; 2004 Jul; 96(1):1-6. PubMed ID: 15203254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-induced long QT syndrome and torsade de pointes.
    Morissette P; Hreiche R; Turgeon J
    Can J Cardiol; 2005 Aug; 21(10):857-64. PubMed ID: 16107909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. QT interval prolongation and torsade de pointes.
    Patanè S; Marte F; Di Bella G
    Int J Cardiol; 2009 Jan; 131(2):e51-3. PubMed ID: 17689729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case report of phenothiazine-induced torsade de pointes.
    Wilson WH; Weiler SJ
    Am J Psychiatry; 1984 Oct; 141(10):1265-6. PubMed ID: 6148894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolonged QT interval and torsade de pointes following astemizole overdose.
    Saviuc P; Danel V; Dixmerias F
    J Toxicol Clin Toxicol; 1993; 31(1):121-5. PubMed ID: 8433408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Torsade de pointes following intravenous haloperidol administration in a patient with complete heart block.
    Ginwalla M; Biblo LA; Paydak H
    WMJ; 2009 Feb; 108(1):48-50. PubMed ID: 19326637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.